OCULAR THERAPEUTIX, INC Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
OCULAR THERAPEUTIX, INC (OCUL) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $5.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2020-03-12
- OCULAR THERAPEUTIX, INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-12-31 was $0.00.
- OCULAR THERAPEUTIX, INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-09-30 was $0.00.
- OCULAR THERAPEUTIX, INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-06-30 was $9.00K, a 10.00% decline year-over-year.
- OCULAR THERAPEUTIX, INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-03-31 was -$4.00K, a 105.88% decline year-over-year.
- OCULAR THERAPEUTIX, INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2017 was $5.00K, a 92.06% decline from fiscal 2016.
- OCULAR THERAPEUTIX, INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was $63.00K.
- OCULAR THERAPEUTIX, INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2015 was -$68.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $9.00K derived: sum of 3 quarters · filed 2020-03-12 | $5.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $9.00K derived: sum of 2 quarters · filed 2018-11-07 | $5.00K 10-Q · filed 2018-11-07 | -$5.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $9.00K 10-Q · filed 2018-08-07 | $5.00K 10-Q · filed 2018-08-07 | -$5.00K derived: sum of 3 quarters · filed 2019-03-07 | -$10.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$4.00K 10-Q · filed 2018-05-08 | -$14.00K derived: sum of 2 quarters · filed 2019-03-07 | -$19.00K derived: sum of 3 quarters · filed 2019-03-07 | -$9.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$15.00K derived: sum of 2 quarters · filed 2019-03-07 | -$5.00K derived: sum of 3 quarters · filed 2019-03-07 | $63.00K 10-K · filed 2019-03-07 |
| 2016-09-30 | -$5.00K 10-Q · filed 2017-11-07 | $5.00K derived: sum of 2 quarters · filed 2017-11-07 | $73.00K 10-Q · filed 2017-11-07 | $21.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $10.00K 10-Q · filed 2016-08-09 | $78.00K 10-Q · filed 2017-08-08 | $26.00K derived: sum of 3 quarters · filed 2018-03-08 | $18.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $68.00K 10-Q · filed 2017-05-05 | $16.00K derived: sum of 2 quarters · filed 2018-03-08 | $8.00K derived: sum of 3 quarters · filed 2018-03-08 | $0.00 derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$60.00K derived: sum of 2 quarters · filed 2018-03-08 | -$68.00K derived: sum of 3 quarters · filed 2018-03-08 | -$68.00K 10-K · filed 2018-03-08 |
| 2015-09-30 | -$8.00K 10-Q · filed 2016-11-09 | -$16.00K derived: sum of 2 quarters · filed 2016-11-09 | -$16.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$8.00K 10-Q · filed 2016-08-09 | -$8.00K 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |